BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17430871)

  • 21. Megaslope, natural course, and historical controls in amyotrophic lateral sclerosis trials.
    Conradi S; Ronnevi LO
    Adv Neurol; 1995; 68():219-24. PubMed ID: 8787232
    [No Abstract]   [Full Text] [Related]  

  • 22. Kennedy disease mimics amyotrophic lateral sclerosis: a case report.
    Fu MH; Lan MY; Liu JS; Lai SL; Chen SS; Chang YY
    Acta Neurol Taiwan; 2008 Jun; 17(2):99-103. PubMed ID: 18686649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
    Murray LM; Talbot K; Gillingwater TH
    Neuropathol Appl Neurobiol; 2010 Apr; 36(2):133-56. PubMed ID: 20202121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
    Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder.
    Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T
    J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical differentiation between primary lateral sclerosis and upper motor neuron predominant amyotrophic lateral sclerosis.
    Gotkine M; Argov Z
    Arch Neurol; 2007 Oct; 64(10):1545; author reply 1545. PubMed ID: 17923644
    [No Abstract]   [Full Text] [Related]  

  • 28. Babinski and the diagnosis of amyotrophic lateral sclerosis.
    Rowland LP
    Ann Neurol; 1993 Jan; 33(1):108. PubMed ID: 8494329
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum?
    Strong MJ; Gordon PH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):8-16. PubMed ID: 16036421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnosis of amyotrophic lateral sclerosis. A discussion.
    Swash M
    Adv Neurol; 1995; 68():157-60. PubMed ID: 8787226
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demystifying lobar degenerations: tauopathies vs Gehrigopathies.
    Ince PG; Morris JC
    Neurology; 2006 Jan; 66(1):8-9. PubMed ID: 16401836
    [No Abstract]   [Full Text] [Related]  

  • 33. [Amyotrophic lateral sclerosis: Charcot's disease or a syndrome].
    Serratrice G
    Rev Prat; 1990 Sep; 40(21):1966-7. PubMed ID: 2237191
    [No Abstract]   [Full Text] [Related]  

  • 34. ALS and motor neuron disorders today and tomorrow.
    Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Dec; 2(4):171-2. PubMed ID: 11958726
    [No Abstract]   [Full Text] [Related]  

  • 35. [Electrophysiologic assessment in motor neuron diseases].
    Espadaler-Gamissans JM
    Neurologia; 1996 Dec; 11 Suppl 5():20-8. PubMed ID: 9044571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor neuron disorder simulating ALS induced by chronic inhalation of pyrethroid insecticides.
    Doi H; Kikuchi H; Murai H; Kawano Y; Shigeto H; Ohyagi Y; Kira J
    Neurology; 2006 Nov; 67(10):1894-5. PubMed ID: 17130437
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrodiagnostic criteria for ALS: time to STARD.
    Schelhaas HJ; Kleine BU; Zwarts MJ
    Clin Neurophysiol; 2008 Jul; 119(7):1689-90. PubMed ID: 18450507
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic value of satellite potentials in clinical EMG.
    Rowińska-Marcińska K; Ryniewicz B; Hausmanowa-Petrusewicz I; Karwańska A
    Electromyogr Clin Neurophysiol; 1997; 37(8):483-9. PubMed ID: 9444488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidate screening of the bovine and feline spinal muscular atrophy genes reveals no evidence for involvement in human motor neuron disorders.
    Parkinson NJ; Baumer D; Rose-Morris A; Talbot K
    Neuromuscul Disord; 2008 May; 18(5):394-7. PubMed ID: 18395445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.